Skip to main content
. Author manuscript; available in PMC: 2022 Jun 20.
Published in final edited form as: J Surg Oncol. 2012 May 24;106(5):532–542. doi: 10.1002/jso.23162

TABLE I.

FDG Imaging Results in Cancer Patients With Adrenal Incidentaloma

Study Number of patients Method of assessment for malignancy Sensitivity for malignancy Specifcity for malignancy Accuracy for malignancy % malignant lesion Mean SUVmax Benign Mean SUVmax malignant
[32] 93 SUVmax >3.2 95.2% 81.3% 88% 35.9% 2.4 8.4
Adr SUVmax/Liver SUVmax > 1.6 92.9% 86.7% 79.6%
SUVmax>2.8 and <10% of pixels <0 HU 100% 97.3% 95.7%
[31] 81 SUVmax ≥ 4.2 88.6% 88.2% 88.5% 67.3% 3.0 8.8
Adr SUVmax/Liver SUVavg > 1.68 90% 91.1% 90.4%
[35] 105 Visual ≥ liver 94% 83% 90% 61% 2.4 6.0–8.4
[37] 109 Visual >> Liver 97% 94% 45% 2.29 12.2
Adr SUVmax/Liver SUVmax >1 100% 100%
[109] 96 Adr SUVavg/Liver SUVavg ≥1 83.3% 85.4% 85% 26.8% 1.9 a 7.2 a
[36] b 59 Visual>liver 75% 89% 86.4% 20% 4.2 9.2
Adr SUVmax/Liver SUVavg ≥ 1.0 100% 95.7% 96.6%
[34] 74 Visual > Liver 93% 96% 95% 37.5% 2.6 5.5
SUVmax > 3.4 95% 86%
[29] 150 SUVmax>3.1 98.5% 92% 39% 1.78 10.13
SUVmax >3.1 or >10 HU 100% 98%
[30] 147c SUVmax>3.1 97.3% 75.9% 84.2% 39% 3.0 10.4
Adr SUVmax/Liver SUVavg >1 97.3% 65.5% 77.9%

Adr, adrenal; Liv, liver.

a

Mean SUVavg values.

b

Recalculated from data provided in article.

c

Lung cancer only.